Pancragen 20 mg

Pancragen is a short tetrapeptide bioregulator that targets pancreatic tissue, part of the well-known Khavinson family of peptide bioregulators. It is best known in research for studying how very small peptide sequences interact with pancreatic cell models, and its compact, tissue-specific design is what makes it stand out.

It also sits on an established research base, with work exploring short peptides and glucose-regulation systems in the lab (Khavinson & Anisimov, 2009). That track record is why it often turns up as a reference compound in this kind of study.

Research Applications

Supplied as a lyophilized powder for stability.